EMSTER KURT VON

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
EMSTER KURT VON's trades of Cymabay Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-29 2023-09-29
PrS Proposed sale
88,036
458.29
US$1,587,604 		88,036 458.29 US$1,587,604
2023-09-29 2023-09-29
PlS Planned sale
50,584 +11.5%
94.10
US$245,154 		50,584 +11.5% 94.10 US$245,154
2023-04-14 2023-04-13
S Sale
54,987 -11.1%
193.11
US$65,128 		54,987 -11.1% 193.11 US$65,128
2023-04-13 2023-04-13
PrS Proposed sale
9,075
1.49
US$13,524 		9,075 1.49 US$13,524
2020-06-18 2020-06-16
US Vaxcyte Inc (PCVX)
B Purchase
12,500 +0.3%
16.00
US$200,000 		12,500 +0.3% 16.00 US$200,000